Medical AI

A new $4,000-a-year service combines genomics and AI for proactive health. But as SONATA launches, it exposes the deep divide in our digital future.

Astrana Health is betting big on two veteran executives to scale its AI-driven model. This move isn't just about growth—it's about execution in a booming market.

A new FDA-cleared robotic system from ZETA SURGICAL promises to deliver mental health therapy with surgical precision, potentially revolutionizing access for millions.

Diagens Technology's iMedLoop platform isn't just a product launch; it's the foundation of a state-aligned strategy to dominate global medical AI.

MindRank's AI platform propelled a GLP-1 drug to Phase III in record time. Its new $52M funding aims to prove this isn't a one-off, but a revolution.

Viz.ai expands its AI care platform into neurodegenerative disease, partnering with Cortechs.ai to bring quantitative neuroimaging to nearly 2,000 hospitals.

A new India-US health alliance leverages 5G and AI, signaling a shift where private foundations and tech infrastructure are redrawing the map of global health.

AI can now find hidden heart risks in old CT scans, a market set to boom. But as doctors warn, the code is the easy part; the human factor is not.

The 2026 stroke care overhaul is more than a medical update; it's a market shockwave forcing hospitals into a multi-billion dollar tech race. Who wins?

New AI tools are moving beyond if a cognitive task is done to how. This shift promises earlier detection, personalized care, and a new era for brain health.

Covera Health's new Chief Clinical Officer isn't just another exec. Dr. Evan Raff's unique background signals a shift from AI hype to real-world results.

CorePlus's landmark integration of an AI-powered test marks a pivotal moment for personalized medicine and health equity in the Caribbean.

With a new $110M raise and rare profitability, Pearl Health's platform isn't just predicting illness—it's proving that technology can fix healthcare's broken model.

With trial delays costing millions daily, Spectrum Science hires Marie Emms to fuse 30 years of experience with AI—a strategic move aimed at market dominance.

With a major stake in Boohee Health, Ant Group is moving beyond finance, using its AI powerhouse AQ to tackle China's health challenges. What does this mean for the future of super apps and personal well-being?

A new class of cranial implant turns the skull into an ultrasound-penetrable window, promising to cut costs, reduce radiation, and transform patient monitoring.

An award for 'Digital Twins' is more than a trophy. It marks a pivotal shift from static data to predictive intelligence, redefining resilience in pharma.

Beyond the hype, an AI assistant is quietly revolutionizing patient care. We explore how Counterpart Health's tool is bridging critical gaps and what it means for doctors and patients.

Canon's new AI for CT scanners promises near-photon-counting quality. Is this a true leap forward for diagnostics or a clever stopgap in a competitive market?

Austin startup Medavize is betting its AI platform can solve caregiver burnout. But in a crowded market, is its signal strong enough to cut through the noise?